Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biosensor detection of triplex formation by modified oligonucleotides.

Paula J Bates1, James F Reddoch, Pintusorn Hansakul

  • 1Department of Medicine and James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.

Analytical Biochemistry
|August 31, 2002
PubMed
Summary

Modified oligonucleotides are crucial for gene modulation therapies due to DNA instability. A biosensor effectively compared modified DNA triplex formation, identifying beneficial RNA modifications and detrimental backbone substitutions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Surgical Outcomes Before and After Instituting a New Ophthalmology Residency Program at a Veterans Affairs Medical Center.

Military medicine·2026
Same author

Protective effects of the ethanolic extract from the Benjakul remedy against oxidative stress and inflammation.

Journal of advanced pharmaceutical technology & research·2026
Same author

Ligand and Linkage Isomers of Bis(ethylthiocarbamato) Copper Complexes with Cyclic C<sub>6</sub>H<sub>8</sub> Backbone Substituents: Synthesis, Characterization, and Antiproliferation Activity.

European journal of inorganic chemistry·2024
Same author

Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic Genes.

Current oncology (Toronto, Ont.)·2024
Same author

Out of sight, but not out of mind: Zoster sine herpete case study and survey of Zoster Eye Disease Study (ZEDS) Group.

American journal of ophthalmology case reports·2024
Same author

Plasma Thermogram Parameters Differentiate Status and Overall Survival of Melanoma Patients.

Current oncology (Toronto, Ont.)·2023

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biotechnology

Background:

  • DNA oligonucleotides exhibit instability in biological settings, necessitating backbone modifications for therapeutic applications like antisense or antigene therapies.
  • Targeting specific gene expression requires stable oligonucleotide designs for effective modulation.

Purpose of the Study:

  • To evaluate the utility of a surface plasmon resonance biosensor (BIAcore) for assessing triplex-directed binding of modified oligonucleotides.
  • To compare the efficacy of various modified oligonucleotide backbones in forming stable triplex structures with a target DNA sequence.

Main Methods:

  • Utilized a BIAcore surface plasmon resonance biosensor to analyze oligonucleotide-DNA interactions.
  • Optimized experimental conditions to minimize non-specific binding and assess triplex formation.

Related Experiment Videos

  • Compared pyrimidine oligonucleotides with modified backbones (RNA, 2'-O-methyl RNA, phosphorothioate, phosphotriester) for triplex stability.

    • Main Results:

    • The biosensor successfully determined the triplex-forming abilities of pyrimidine oligonucleotides with diverse modified backbones.
    • RNA and 2'-O-methyl RNA modifications enhanced triplex formation.
    • Phosphorothioate and phosphotriester backbone substitutions abrogated triplex formation.
    • Biosensor results were consistent with DNase I footprinting data.

    Conclusions:

    • Surface plasmon resonance biosensing is a reliable method for evaluating modified oligonucleotide triplex formation.
    • Specific backbone modifications, such as RNA and 2'-O-methyl RNA, are beneficial for enhancing triplex stability in gene modulation strategies.
    • Certain backbone modifications, like phosphorothioate and phosphotriester, hinder therapeutic oligonucleotide efficacy.